(1-(4-Fluoro-3-hydroxybenzoyl)piperidin-4-yl)(4-isopropylphenyl)methanone

ID: ALA4534867

PubChem CID: 155549206

Max Phase: Preclinical

Molecular Formula: C22H24FNO3

Molecular Weight: 369.44

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1ccc(C(=O)C2CCN(C(=O)c3ccc(F)c(O)c3)CC2)cc1

Standard InChI:  InChI=1S/C22H24FNO3/c1-14(2)15-3-5-16(6-4-15)21(26)17-9-11-24(12-10-17)22(27)18-7-8-19(23)20(25)13-18/h3-8,13-14,17,25H,9-12H2,1-2H3

Standard InChI Key:  BFSWPHDXOKWWQJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   15.4191   -3.8534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1287   -3.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1259   -2.6213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4173   -2.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8371   -3.8514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8383   -4.6686    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5441   -3.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2508   -3.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9558   -3.4486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9587   -2.6311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2505   -2.2214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5394   -2.6293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6673   -2.2240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3741   -2.6342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6691   -1.4068    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3674   -3.4514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0734   -3.8615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7830   -3.4544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7822   -2.6330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0756   -2.2266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0712   -4.6787    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7110   -3.4444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7106   -2.6248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0026   -2.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2952   -2.6258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4903   -3.8636    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.0020   -1.3995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 22  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4 23  1  0
  2  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 14  1  0
 17 21  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 18 26  1  0
 24 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4534867

    ---

Associated Targets(Human)

ABHD6 Tchem Monoacylglycerol lipase ABHD6 (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FAAH Tchem Anandamide amidohydrolase (3465 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGLL Tchem Monoglyceride lipase (1909 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABHD12 Tchem Monoacylglycerol lipase ABHD12 (195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.44Molecular Weight (Monoisotopic): 369.1740AlogP: 4.39#Rotatable Bonds: 4
Polar Surface Area: 57.61Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.75CX Basic pKa: CX LogP: 4.18CX LogD: 4.02
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.81Np Likeness Score: -0.97

References

1. Granchi C, Lapillo M, Glasmacher S, Bononi G, Licari C, Poli G, El Boustani M, Caligiuri I, Rizzolio F, Gertsch J, Macchia M, Minutolo F, Tuccinardi T, Chicca A..  (2019)  Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.,  62  (4): [PMID:30715876] [10.1021/acs.jmedchem.8b01483]

Source